Therapeutic class
Orthopedics
Pendopharm
With a strategic focus on growth, PENDOPHARM is actively engaged in licensing, partnering, developing and marketing specialty prescription medicines as well as consumer healthcare products.
Find out more about PENDOPHARMFrom allergy to gastroenterology to specialty prescription products, PENDOPHARM specialises in several different therapeutic classes.
READ MOREDiscover our range of innovative products.
PENDOPHARM offers a large line of over-the-counter and behind-the-counter products as well as a broad portfolio of prescription/specialty products in several therapeutic areas.
See all products1 / 12
Colonoscopy Preparations
Therapeutic Area
Gastroenterology
Entocort
Therapeutic Class
Gastroenterology
Esenvia
Therapeutic class
Chronic Venous Insufficiency (CVI)/ Varicose veins
Glatect
Therapeutic class
Neurology
Helixia
Therapeutic class
Cough & Cold
Hemovel
Therapeutic class
Oral Hemorrhoid Treatment
Instillagel
Therapeutic class
Topical Anaesthetic/Antiseptic
Jelido
Therapeutic class
Urology
Lax-A
Therapeutic class
Laxative
pdp-AMLODIPINE
Therapeutic class
Cardiology
-
August 1, 2019 PENDOPHARM launches ELEVIEWTM in Canada (submucosal injectable composition 10mL)
PENDOPHARM, a division of Pharmascience Inc., headquartered in Montreal, Canada, announced today the launch in Canada of ELEVIEW™. ELEVIEW™ is the first all-in-one submucosal injectable composition intended for use in endoscopic resection procedures for submucosal lift of polyps, adenomas or other gastrointestinal (GI) mucosal lesions in the colon, prior to excision with a snare or endoscopic device.
Read More -
December 13, 2018 GLATECT(TM) IS NOW COVERED BY THE PROVINCIAL DRUG PLAN IN BRITISH COLUMBIA FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS).
Read More -
November 12, 2018 PENDOPHARM, a division of PHARMASCIENCE INC wins the D.W. BOLE award
Read More
